Breast Cancer Clinical Trial Using pertuzumab, trastuzumab, Aromatase Inhibitor and Induction Chemotherapy

- The folks at Hoffmann-La Roche are studying the effects of pertuzumab; trastuzumab; Aromatase Inhibitor; Induction Chemotherapy on Breast Cancer in females ages 18 years and older. This clinical trial is slated to start February 2012 and is expected to end circa June 2016.

888-662-6728 (U.S. Only)
Reference Study ID Number: MO27775
Overall Study Contact Info
StatusName Contact Phone
RecruitingReference Study ID Number: MO27775 (U.S. Only)

This study is officially titled, "A Randomized, Two-arm, Open-label, Multicenter Phase II Trial Assessing the Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab Plus an Aromatase Inhibitor in First Line Patients With HER2-positive and Hormone Receptor-positive Advanced (Metastatic or Locally Advanced) Breast Cancer.."


Caceres, Spain - Active, not recruiting

Barcelona, Spain - Recruiting

Barcelona, Spain - Active, not recruiting

La Coruna, La Coru¤a - Recruiting

San Sebastian, Guipuzcoa - Recruiting

San Sebastian, Guipuzcoa - Recruiting

Vicenza, Veneto - Terminated

Trento, Trentino-Alto Adige - Terminated

Prato, Toscana - Recruiting

Firenze, Toscana - Recruiting

Coventry, United Kingdom - Recruiting

Chandler, Arizona - Recruiting

Birmingham, Alabama - Recruiting

Catania, Sicilia - Completed

Besancon, France - Recruiting

Sao Paulo, SP - Recruiting

Lecce, Puglia - Recruiting

Brindisi, Puglia - Recruiting

Sao Paulo, SP - Recruiting

Sao Paulo, SP - Active, not recruiting

Sao Paulo, SP - Active, not recruiting

Bari, Puglia - Recruiting

Pavia, Lombardia - Recruiting

Milano, Lombardia - Recruiting

Castellanza, Lombardia - Recruiting

Brescia, Lombardia - Terminated

Sora, Lazio - Recruiting

Pordenone, Friuli-Venezia Giulia - Recruiting

Swindon, United Kingdom - Recruiting

Sheffield, United Kingdom - Recruiting

Scarborough, United Kingdom - Recruiting

Portsmouth, United Kingdom - Recruiting

London, United Kingdom - Recruiting

Glasgow, United Kingdom - Recruiting

Temple, Texas - Recruiting

Lake Success, New York - Completed

Houston, Texas - Recruiting

Pittsburgh, Pennsylvania - Recruiting

Lake Success, New York - Recruiting

Voorhees, New Jersey - Recruiting

Morristown, New Jersey - Recruiting

St. Louis, Missouri - Recruiting

Bethesda, Maryland - Recruiting

Baltimore, Maryland - Completed

Marrero, Louisiana - Recruiting

Wichita, Kansas - Recruiting

Marietta, Georgia - Recruiting

Atlanta, Georgia - Recruiting

Miami, Florida - Recruiting

Norwalk, Connecticut - Recruiting

Denver, Colorado - Recruiting

Burbank, California - Recruiting

Bakersfield, California - Recruiting

Hot Springs, Arkansas - Active, not recruiting

Parma, Emilia-Romagna - Recruiting

Bologna, Emilia-Romagna - Not yet recruiting

Napoli, Campania - Terminated

Napoli, Campania - Recruiting

Pune, India - Recruiting

New Delhi, India - Recruiting

Mumbai, India - Recruiting

Chennai, India - Recruiting

Bangalore, India - Recruiting

Vandoeuvre Les Nancy, France - Recruiting

Toulouse, France - Recruiting

Senlis, France - Recruiting

Nice, France - Recruiting

Nantes, France - Recruiting

Marseille, France - Recruiting

Lyon, France - Recruiting

Clermont Ferrand, France - Recruiting

Brest, France - Recruiting

Boulogne Sur Mer, France - Recruiting

Bordeaux, France - Recruiting

Castellon, Spain - Active, not recruiting

Cordoba, Spain - Active, not recruiting

La Coru¤a, Spain - Active, not recruiting

Lerida, Spain - Active, not recruiting

Madrid, Spain - Recruiting

Madrid, Spain - Recruiting

Murcia, Spain - Recruiting

Sevilla, Spain - Recruiting

Valencia, Spain - Active, not recruiting

Zaragoza, Spain - Recruiting

Ankara, Turkey - Terminated

Ankara, Turkey - Recruiting

Istanbul, Turkey - Recruiting

Izmir, Turkey - Recruiting

Malatya, Turkey - Recruiting

S?hhiye, ANKARA, Turkey - Recruiting

Trabzon, Turkey - Terminated

Brighton, United Kingdom - Recruiting

Chelmsford, United Kingdom - Recruiting

For more study details, please visit this link to record, which is the source of this webpage.